Your browser doesn't support javascript.
loading
Arsenic trioxide blocked proliferation and cardiomyocyte differentiation of human induced pluripotent stem cells: Implication in cardiac developmental toxicity.
Bao, Zhengyi; Han, Zhenbo; Zhang, Bo; Yu, Ying; Xu, Zihang; Ma, Wenya; Ding, Fengzhi; Zhang, Lai; Yu, Meixi; Liu, Shenzhen; Jin, Mengyu; Yan, Gege; Huang, Qi; Wang, Xiuxiu; Hua, Bingjie; Yang, Fan; Li, Yuan; Liu, Yu; Zagidullin, Naufal; Carvalho, Katherine; Li, Baoxin; Wang, Ning; Cai, Benzhi.
Afiliação
  • Bao Z; Department of Pharmacy at the Second Affiliated Hospital, Department of Pharmacology (The Key Laboratory of Cardiovascular Research, Ministry of Education) at College of Pharmacy, Harbin Medical University, Harbin 150086, China.
  • Han Z; Department of Pharmacy at the Second Affiliated Hospital, Department of Pharmacology (The Key Laboratory of Cardiovascular Research, Ministry of Education) at College of Pharmacy, Harbin Medical University, Harbin 150086, China.
  • Zhang B; Department of Pharmacy at the Second Affiliated Hospital, Department of Pharmacology (The Key Laboratory of Cardiovascular Research, Ministry of Education) at College of Pharmacy, Harbin Medical University, Harbin 150086, China.
  • Yu Y; Department of Pharmacy at the Second Affiliated Hospital, Department of Pharmacology (The Key Laboratory of Cardiovascular Research, Ministry of Education) at College of Pharmacy, Harbin Medical University, Harbin 150086, China.
  • Xu Z; Department of Pharmacy at the Second Affiliated Hospital, Department of Pharmacology (The Key Laboratory of Cardiovascular Research, Ministry of Education) at College of Pharmacy, Harbin Medical University, Harbin 150086, China.
  • Ma W; Department of Pharmacy at the Second Affiliated Hospital, Department of Pharmacology (The Key Laboratory of Cardiovascular Research, Ministry of Education) at College of Pharmacy, Harbin Medical University, Harbin 150086, China.
  • Ding F; Department of Pharmacy at the Second Affiliated Hospital, Department of Pharmacology (The Key Laboratory of Cardiovascular Research, Ministry of Education) at College of Pharmacy, Harbin Medical University, Harbin 150086, China.
  • Zhang L; Department of Pharmacy at the Second Affiliated Hospital, Department of Pharmacology (The Key Laboratory of Cardiovascular Research, Ministry of Education) at College of Pharmacy, Harbin Medical University, Harbin 150086, China.
  • Yu M; Department of Pharmacy at the Second Affiliated Hospital, Department of Pharmacology (The Key Laboratory of Cardiovascular Research, Ministry of Education) at College of Pharmacy, Harbin Medical University, Harbin 150086, China.
  • Liu S; Department of Pharmacy at the Second Affiliated Hospital, Department of Pharmacology (The Key Laboratory of Cardiovascular Research, Ministry of Education) at College of Pharmacy, Harbin Medical University, Harbin 150086, China.
  • Jin M; Department of Pharmacy at the Second Affiliated Hospital, Department of Pharmacology (The Key Laboratory of Cardiovascular Research, Ministry of Education) at College of Pharmacy, Harbin Medical University, Harbin 150086, China.
  • Yan G; Department of Pharmacy at the Second Affiliated Hospital, Department of Pharmacology (The Key Laboratory of Cardiovascular Research, Ministry of Education) at College of Pharmacy, Harbin Medical University, Harbin 150086, China.
  • Huang Q; Department of Pharmacy at the Second Affiliated Hospital, Department of Pharmacology (The Key Laboratory of Cardiovascular Research, Ministry of Education) at College of Pharmacy, Harbin Medical University, Harbin 150086, China.
  • Wang X; Department of Pharmacy at the Second Affiliated Hospital, Department of Pharmacology (The Key Laboratory of Cardiovascular Research, Ministry of Education) at College of Pharmacy, Harbin Medical University, Harbin 150086, China.
  • Hua B; Department of Pharmacy at the Second Affiliated Hospital, Department of Pharmacology (The Key Laboratory of Cardiovascular Research, Ministry of Education) at College of Pharmacy, Harbin Medical University, Harbin 150086, China.
  • Yang F; Department of Pharmacy at the Second Affiliated Hospital, Department of Pharmacology (The Key Laboratory of Cardiovascular Research, Ministry of Education) at College of Pharmacy, Harbin Medical University, Harbin 150086, China.
  • Li Y; Department of Pharmacy at the Second Affiliated Hospital, Department of Pharmacology (The Key Laboratory of Cardiovascular Research, Ministry of Education) at College of Pharmacy, Harbin Medical University, Harbin 150086, China.
  • Liu Y; Department of Pharmacy at the Second Affiliated Hospital, Department of Pharmacology (The Key Laboratory of Cardiovascular Research, Ministry of Education) at College of Pharmacy, Harbin Medical University, Harbin 150086, China.
  • Zagidullin N; Department of Internal Diseases, Bashkir State Medical University, Ufa, Russia.
  • Carvalho K; Cell Therapy and Biotechnology in Regenerative Medicine Research Group, Pequeno Príncipe Faculty, Pelé Pequeno Príncipe Institute, Curitiba, Brazil.
  • Li B; Department of Pharmacy at the Second Affiliated Hospital, Department of Pharmacology (The Key Laboratory of Cardiovascular Research, Ministry of Education) at College of Pharmacy, Harbin Medical University, Harbin 150086, China. Electronic address: libx64@hotmail.com.
  • Wang N; Department of Pharmacy at the Second Affiliated Hospital, Department of Pharmacology (The Key Laboratory of Cardiovascular Research, Ministry of Education) at College of Pharmacy, Harbin Medical University, Harbin 150086, China. Electronic address: wangning@ems.hrbmu.edu.cn.
  • Cai B; Department of Pharmacy at the Second Affiliated Hospital, Department of Pharmacology (The Key Laboratory of Cardiovascular Research, Ministry of Education) at College of Pharmacy, Harbin Medical University, Harbin 150086, China; Department of Internal Diseases, Bashkir State Medical University, Ufa,
Toxicol Lett ; 309: 51-58, 2019 Jul.
Article em En | MEDLINE | ID: mdl-30946857

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Miócitos Cardíacos / Células-Tronco Pluripotentes Induzidas / Trióxido de Arsênio Limite: Humans Idioma: En Revista: Toxicol Lett Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Miócitos Cardíacos / Células-Tronco Pluripotentes Induzidas / Trióxido de Arsênio Limite: Humans Idioma: En Revista: Toxicol Lett Ano de publicação: 2019 Tipo de documento: Article